Search research articles
Contact Us
Filters
Showing results (181-190 of 241) with videos related to
Page
of 25
Sort By:
Journal of Occupational and Environmental Hygiene
|
July 9, 2004
A summary of the workshop applying biomarkers to occupational health practice
D Gayle DeBord, Russell E Savage, Hans Drexler, et al.
Global Advances in Health and Medicine
|
August 28, 2019
Acupressure to Reduce Treatment-Related Symptoms for Children With Cancer and Recipients of Hematopoietic Stem Cell Transplant: Protocol for a Randomized Controlled Trial
E Anne Lown, Anu Banerjee, Eric Vittinghoff, et al.
The EMBO Journal
|
October 4, 2021
CDKL5 kinase controls transcription-coupled responses to DNA damage
Taran Khanam, Ivan Muñoz, Florian Weiland, et al.
The New England Journal of Medicine
|
May 3, 2008
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
Richard F Schlenk, Konstanze Döhner, Jürgen Krauter, et al.
Oncoimmunology
|
September 17, 2025
Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblasts
Robert Polten, Ivana Kutle, Jan Lennart Stalp, et al.
European Journal of Pharmacology
|
March 25, 2008
Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonist
John W Adams, Juan Ramirez, Danny Ortuno, et al.
Cell Reports
|
October 13, 2021
Tracing the emergence of primordial germ cells from bilaminar disc rabbit embryos and pluripotent stem cells
Toshihiro Kobayashi, Aracely Castillo-Venzor, Chris A Penfold, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 25, 2009
APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology
John W Adams, Juan Ramirez, Yunqing Shi, et al.
Current Cancer Drug Targets
|
June 21, 2016
Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening
Amit Sharma, Nidhi Jyotsana, Courteney K Lai, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 7, 2008
Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization
William J Thomsen, Andrew J Grottick, Frederique Menzaghi, et al.
Page
of 25
Search research articles
Search
Showing results (181-190 of 241) with videos related to
Sort By:
Page
of 25
Journal of Occupational and Environmental Hygiene
|
July 9, 2004
A summary of the workshop applying biomarkers to occupational health practice
D Gayle DeBord, Russell E Savage, Hans Drexler, et al.
Global Advances in Health and Medicine
|
August 28, 2019
Acupressure to Reduce Treatment-Related Symptoms for Children With Cancer and Recipients of Hematopoietic Stem Cell Transplant: Protocol for a Randomized Controlled Trial
E Anne Lown, Anu Banerjee, Eric Vittinghoff, et al.
The EMBO Journal
|
October 4, 2021
CDKL5 kinase controls transcription-coupled responses to DNA damage
Taran Khanam, Ivan Muñoz, Florian Weiland, et al.
The New England Journal of Medicine
|
May 3, 2008
Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia
Richard F Schlenk, Konstanze Döhner, Jürgen Krauter, et al.
Oncoimmunology
|
September 17, 2025
Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblasts
Robert Polten, Ivana Kutle, Jan Lennart Stalp, et al.
European Journal of Pharmacology
|
March 25, 2008
Anti-thrombotic and vascular effects of AR246686, a novel 5-HT2A receptor antagonist
John W Adams, Juan Ramirez, Danny Ortuno, et al.
Cell Reports
|
October 13, 2021
Tracing the emergence of primordial germ cells from bilaminar disc rabbit embryos and pluripotent stem cells
Toshihiro Kobayashi, Aracely Castillo-Venzor, Chris A Penfold, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 25, 2009
APD791, 3-methoxy-n-(3-(1-methyl-1h-pyrazol-5-yl)-4-(2-morpholinoethoxy)phenyl)benzamide, a novel 5-hydroxytryptamine 2A receptor antagonist: pharmacological profile, pharmacokinetics, platelet activity and vascular biology
John W Adams, Juan Ramirez, Yunqing Shi, et al.
Current Cancer Drug Targets
|
June 21, 2016
Pyrimethamine as a Potent and Selective Inhibitor of Acute Myeloid Leukemia Identified by High-throughput Drug Screening
Amit Sharma, Nidhi Jyotsana, Courteney K Lai, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
February 7, 2008
Lorcaserin, a novel selective human 5-hydroxytryptamine2C agonist: in vitro and in vivo pharmacological characterization
William J Thomsen, Andrew J Grottick, Frederique Menzaghi, et al.
Page
of 25